Content ID


Bayer wins another Roundup trial

Jury rules that Roundup herbicide did not cause the plaintiff’s cancer in Shelton v. Monsanto

A Kansas City, Missouri, jury has ruled in favor of Bayer in the Shelton v. Monsanto trial in which the plaintiff Allan Shelton charged that Roundup (which contains the active ingredient glyphosate) caused his cancer. 

Following the trial, Bayer (which bought Monsanto in 2018) issued this statement: 

“The jury’s verdict in favor of the company brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer and was not the cause of Mr. Shelton’s cancer. These conclusions are consistent with the assessments of expert regulators worldwide as well as the overwhelming evidence from four decades of scientific studies concluding that Roundup can be used safely and is not carcinogenic. While we have great sympathy for Mr. Shelton, the jury has weighed the evidence from both sides in this case and concluded that Roundup is not responsible for his injuries.”

This marks the third consecutive trial win for Bayer, following favorable verdicts in Clark v. Monsanto and Stephens v. Monsanto. Juries in three previous trials had ruled against Bayer. 

Bayer is currently asking the U.S. Supreme Court to overturn a $25-million award in Hardeman v. Monsanto Co. to Edwin Hardeman, a California man who blamed Roundup herbicide for giving him cancer. The appeal is part of Bayer’s plan to resolve billions of dollars of claims against Roundup and its active ingredient, glyphosate

Read more about

Talk in Marketing